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Abstract
Background: Patients with a primary pure seminoma in the testis who have elevated serum alpha-fetoprotein are
rare and should be treated as patients with nonseminomatous germ cell tumors. However, nonpalpable testicular
tumors in this condition have never been reported. We describe a case of nonpalpable pure testicular seminoma
with elevated serum alpha-fetoprotein presenting retroperitoneal metastasis.
Case presentation: A 29-year-old Asian man was referred to our hospital with right flank pain. Computed
tomography showed a mass located between his aorta and inferior vena cava, but a testicular tumor was not
detected. His serum levels of lactate dehydrogenase, alpha-fetoprotein, and DUPAN-2 were high. Although no
tumor or nodule was palpable in his testis, ultrasonography revealed multiple low echoic lesions in his right
testicular parenchyma. He was diagnosed with right testicular cancer with retroperitoneal lymph node metastasis
and underwent right high orchiectomy. A pathological examination revealed pure seminoma and no
nonseminomatous components were found in the specimen. Three courses of induction systemic chemotherapy
(cisplatin, etoposide, and bleomycin) normalized his serum alpha-fetoprotein and DUPAN-2 levels. Three additional
courses of chemotherapy (etoposide and bleomycin) were performed, and treatment was completed with
laparoscopic retroperitoneal lymph node dissection. Pathology of the dissected specimen showed fibrous and
necrotic tissue with no viable cells. He is alive without recurrence 54 months after orchiectomy.
Conclusions: We report a case of pure testicular seminoma with elevated serum alpha-fetoprotein and DUPAN-2
presenting retroperitoneal metastasis. We recommend an ultrasound examination of bilateral testes when large
retroperitoneal tumors are detected in young men, even if a mass is not palpable in the scrotum.
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Background
Testicular cancers are categorized into seminomatous
and non-seminomatous germ cell tumors (NSGCTs),
each with a 50 % incidence. Distinguishing NSGCTs
from seminomas is important because the therapeutic
strategy is different. Many patients with NSGCT have
elevated serum tumor markers, such as lactate de-
hydrogenase (LDH), alpha-fetoprotein (AFP), and
human chorionic gonadotropin (hCG). Since semi-
noma does not induce AFP production, the guidelines
recommend that cases with increased AFP levels be
treated as cases of NSGCT [1, 2]. Because, there is a
possibility that a hidden focus of NSGCTs like yolk
sac tumor is somewhere present. However, in the lit-
erature, few cases have been described of patients
with histologically pure seminoma presenting with el-
evated serum AFP levels [3–5].
We report a case of a 29-year-old Asian man with
nonpalpable testicular cancer presenting retroperitoneal
lymph node metastasis. Although his testicular histology
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showed pure seminoma at orchiectomy, preoperative
serum AFP levels were elevated.
Case presentation
A 29-year-old Asian man with no remarkable past
history was referred to our hospital presenting with
right flank pain. He had an episode of right flank
pain 2 weeks before the first visit. Computed tomog-
raphy (CT) revealed a retroperitoneal mass (52×36×31
mm) located between his aorta and inferior vena cava
(Fig. 1a), but a testicular tumor was not detected in
his testis. His serum levels of LDH, AFP, and
DUPAN-2 were high (327 U/l, 29.6 ng/ml, and higher
than measurable range, 1600 U/ml, respectively).
Serum levels of other tumor markers, such as hCG,
carcinoembryonic antigen, carbohydrate antigen 19–9,
and soluble interleukin 2 receptor, were within the
normal range (1.1 mIU/ml, 2.7 ng/ml, 27.9 U/ml, and
157 U/ml, respectively). Although no tumor or nodule
was palpable in either testis, ultrasonography revealed
multiple low echoic lesions in his right testicular par-
enchyma (Fig. 1b). He was diagnosed with right tes-
ticular cancer with retroperitoneal metastasis, and
underwent right high orchiectomy (Fig. 2a). A patho-
logical examination revealed pure seminoma (Fig. 2b);
fibrous foci were diffusely observed (Fig. 2c) and no
nonseminomatous components were found in the spe-
cimen. Because his preoperative serum AFP levels
were high, induction chemotherapy combining cis-
platin, etoposide, and bleomycin (BEP), was per-
formed. After three courses, his serum AFP and
DUPAN-2 levels were normalized. The volume of his
retroperitoneal mass decreased to 15×10×7 mm after
three additional courses of chemotherapy combining
etoposide and cisplatin (EP). Finally, laparoscopic
retroperitoneal lymph node dissection (RPLND) was
performed, and pathology of the dissected specimen
showed fibrous and necrotic tissue with no viable
cells (Fig. 3d). He is alive without recurrence 54
months after orchiectomy.
Discussion
Patients with elevated serum AFP levels and a pri-
mary pure seminoma are treated as patients with
NSGCTs, because some nonseminomatous compo-
nents are presumed to be present either in the testis
or at a metastatic site. Therefore, we treated the
current case as NSGCTs, and induction chemotherapy
followed by RPLND was performed after orchiectomy
as in stage IIB NSGCTs. Peterson et al. [5] reported
42 cases with pure seminoma at orchiectomy and
showing elevated serum AFP levels. They performed
combination chemotherapy based on platinum reagent
followed by RPLND. Viable cancer cells were ob-
served in the retroperitoneal lymph nodes of 15 pa-
tients (37.5 %) with pure seminoma showing elevated
serum AFP levels. In general, 16.9 % of patients with
stage II or greater pure seminoma without elevated
serum AFP levels have viable cancer cells in their
retroperitoneal lymph nodes [6]; of the patients with
NSGCTs who have retroperitoneal lymph node
metastases, 12.2 % have viable cancer cells in their
retroperitoneal lymph nodes after chemotherapy [7].
Therefore, pure seminomas with elevated serum AFP
levels have a relatively lower sensitivity to chemother-
apy than pure seminomas without elevated serum
AFP levels or NSGCTs. Fortunately, the pathological
examination of the retroperitoneal lymph nodes in
our patient did not reveal viable cancer cells; the
long-term good prognosis suggests that six courses
of BEP and EP chemotherapy were effective in this
patient.
DUPAN-2 is a well-known tumor marker for pancre-
atic, bile duct, and colorectal cancers [8]; in our case,
serum DUPAN-2 levels, as well as AFP, were increased
before orchiectomy. In the literature, only two cases of
embryonal carcinomas with elevated serum DUPAN-2
levels have been reported [9, 10]. Kamoshida et al.
reported immunohistochemical analyses of DUPAN-2
expression using paraffin-embedded specimens of 30
testicular germ cell tumors, and DUPAN-2 was
expressed in all of the specimens from nine patients
a b c
Fig. 1 a Computed tomography shows a retroperitoneal tumor located between the aorta and the inferior vena cava. The size of the tumor
(arrowheads) was 52×36×31 mm, and the testicular tumor was not detected in computed tomography. b Ultrasound examination revealed a tiny
low echoic tumor (arrowheads) and a low echoic mosaic pattern around the tumor. c Microcalcifications of various sizes around the tumor were
detected in ultrasound (arrows)
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with embryonal carcinoma [11]. In our case, before
orchiectomy, our patient’s DUPAN-2 level was higher
than the measurable upper limit and it decreased to
within the normal range after chemotherapy induc-
tion, suggesting that DUPAN-2 in our patient was
produced by a nonseminomatous component like an
embryonal carcinoma.
Seminomas typically appear as solid, round, homo-
geneous, low reflective masses contained within tes-
tes, without calcification inside the tumors. On the
other hand, embryonal carcinomas and teratomas ap-
pear as inhomogeneous masses with calcification in-
side the tumor mass and, generally, a normal gonadal
stroma does not contain calcifications. Miller et al.
reviewed 3854 testicular ultrasound examinations;
they hypothesized that intratesticular microcalcifica-
tions outside the margin of the tumor might repre-
sent a phenomenon of burned-out tumor [12]. In our
case, an ultrasound examination revealed rough
microcalcifications around the intratesticular tumor;
in the orchiectomy specimen (Fig. 1c), many calcifi-
cations and fibrous tissues were detected around the
seminomatous tumor (Fig. 2c). Those findings sug-
gest that the testicular mass might result from a
burned-out phenomenon of an embryonal carcinoma.
Therefore, we performed immunohistochemical ana-
lyses for DUPAN-2 and AFP on the orchiectomy speci-
men and retroperitoneal mass. Immunohistochemical
analyses showed no positive cells for DUPAN-2 or
AFP in the orchiectomy specimen and retroperiton-
eal mass (Fig. 3). If we had obtained a biopsied
retroperitoneal specimen in the first diagnosis, we
might have been able to detect positive cancer cells.
In conclusion, here we report a case of pure testicular
seminoma with elevated serum AFP and DUPAN-2
presenting retroperitoneal metastasis. We recom-
mend an ultrasound examination of bilateral testes
when large retroperitoneal tumors are detected in









Fig. 2 a Macroscopic findings of orchiectomy specimen. A tiny yellowish tumor was observed (*), surrounded by normal tissue (#). b Microscopic
findings of the tiny tumor. Pathological findings revealed a pure seminoma. c Microscopic findings of the tissue around the tumor: calcification






Fig. 3 Hematoxylin and eosin and immunohistochemical staining of the orchiectomy specimen (a, b, c) and of the retroperitoneal dissected
specimen (d, e, f). b and e alpha-fetoprotein staining; c and f DUPAN-2 staining
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Conclusions
We report a case of pure testicular seminoma at orchiec-
tomy with elevated serum AFP and DUPAN-2 presenting
retroperitoneal metastasis. When a retroperitoneal mass
is detected and a testicular tumor is not palpable, we
recommend consideration of the possibility of a testicular
tiny tumor or of a burned-out phenomenon.
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